Collegium Pharmaceutical, Inc. (COLL): Director sold, ~$143K

~$143K
Approx. value · 4,127 sh @ $34.54: 84K
Holds after · shares reported

Traded: May 15, 2026
Filed: May 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Mar 18, 2026InsiderOfficer sold ~$488K of COLL shares in the open market
Mar 19, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
Apr 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 6, 2026, the board of directors (“Board”) of Collegium Pharmaceutical, Inc. (the “Company”) approved the nomination of Michael Donovan to stand for election at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”).”
May 7, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
May 11, 2026InsiderDirector sold ~$323K of COLL shares in the open market
May 12, 2026Company filing · Form 8-K · Acquisition or sale, Executive changeCompleted buying or selling a business or assets, and changed a top executive or board member (and 1 more item)“On May 11, 2026, the Company’s board of directors adopted the Company’s 2026 Inducement Plan (the “ Inducement Plan ”), pursuant to which the Company may grant non-qualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, and dividend equivalent rights with respect to an aggregate of 325,000 shares of the Company’s common stock, par value $0.001…”
May 13, 2026InsiderDirector sold ~$162K of COLL shares in the open market
May 15, 2026 · this disclosureInsiderDirector sold ~$143K of COLL shares in the open market

What came next

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Collegium Pharmaceutical, Inc.

For Collegium Pharmaceutical, Inc., OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COLL page.

Other recent filings by John Gordon Freund, Director

The full history of John Gordon Freund, Director is on the profile page.

Other disclosures at Collegium Pharmaceutical, Inc.

Everything OQRO holds on this company is on its COLL page.

Collegium Pharmaceutical, Inc. (COLL)Director sold ~$143K